{"id":5661,"date":"2006-07-06T09:00:00","date_gmt":"2006-07-06T09:00:00","guid":{"rendered":"https:\/\/www.adacyte.com\/?post_type=scientific-corner&#038;p=5661"},"modified":"2021-07-09T11:14:04","modified_gmt":"2021-07-09T11:14:04","slug":"granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease","status":"publish","type":"scientific-corner","link":"https:\/\/www.adacyte.com\/es\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/","title":{"rendered":"Granulocytapheresis in patients with refractory ocular Behcet&#8217;s disease"},"content":{"rendered":"<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Namba+K&amp;cauthor_id=16395727\">Kenichi Namba<\/a><sup>&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16395727\/#affiliation-1\">1<\/a><\/sup>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Sonoda+KH&amp;cauthor_id=16395727\">Koh-Hei Sonoda<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Kitamei+H&amp;cauthor_id=16395727\">Hirokuni Kitamei<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Shiratori+K&amp;cauthor_id=16395727\">Kenji Shiratori<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ariyama+A&amp;cauthor_id=16395727\">Akiko Ariyama<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Iwabuchi+K&amp;cauthor_id=16395727\">Kazuya Iwabuchi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ono%C3%A9+K&amp;cauthor_id=16395727\">Kazunori Ono\u00e9<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Saniabadi+AR&amp;cauthor_id=16395727\">Abby R Saniabadi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Inaba+S&amp;cauthor_id=16395727\">Shoichi Inaba<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ishibashi+T&amp;cauthor_id=16395727\">Tatsuro Ishibashi<\/a>,&nbsp;<a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/?term=Ohno+S&amp;cauthor_id=16395727\">Shigeaki Ohno<\/a>, J Clin Apher. 2006 Jul;21(2):121-8<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p>We conclude that granulocytapheresis might be effective and safe for patients with refractory ocular BD. Further studies are necessary to fully evaluate the clinical efficacy of granulocytapheresis for BD.<\/p>\n<\/div>\n\n<div class=\"post-content max-w-987 mx-auto px-20 lg:px-0\">\n<p><a href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16395727\/\" target=\"_blank\" rel=\"noreferrer noopener\">https:\/\/pubmed.ncbi.nlm.nih.gov\/16395727\/<\/a><\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>Kenichi Namba&nbsp;1,&nbsp;Koh-Hei Sonoda,&nbsp;Hirokuni Kitamei,&nbsp;Kenji Shiratori,&nbsp;Akiko Ariyama,&nbsp;Kazuya Iwabuchi,&nbsp;Kazunori Ono\u00e9,&nbsp;Abby R Saniabadi,&nbsp;Shoichi Inaba,&nbsp;Tatsuro Ishibashi,&nbsp;Shigeaki Ohno, J Clin Apher. 2006 Jul;21(2):121-8 We conclude that granulocytapheresis might be effective and safe for patients with refractory ocular BD. Further studies are necessary to fully evaluate the clinical efficacy of granulocytapheresis for BD. https:\/\/pubmed.ncbi.nlm.nih.gov\/16395727\/<\/p>\n","protected":false},"template":"","scientific_tags":[203,396],"class_list":["post-5661","scientific-corner","type-scientific-corner","status-publish","hentry","scientific_tags-behcets-disease","scientific_tags-oftalmology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Granulocytapheresis in patients with refractory ocular Behcet&#039;s disease - Adacyte<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Granulocytapheresis in patients with refractory ocular Behcet&#039;s disease - Adacyte\" \/>\n<meta property=\"og:description\" content=\"Kenichi Namba&nbsp;1,&nbsp;Koh-Hei Sonoda,&nbsp;Hirokuni Kitamei,&nbsp;Kenji Shiratori,&nbsp;Akiko Ariyama,&nbsp;Kazuya Iwabuchi,&nbsp;Kazunori Ono\u00e9,&nbsp;Abby R Saniabadi,&nbsp;Shoichi Inaba,&nbsp;Tatsuro Ishibashi,&nbsp;Shigeaki Ohno, J Clin Apher. 2006 Jul;21(2):121-8 We conclude that granulocytapheresis might be effective and safe for patients with refractory ocular BD. Further studies are necessary to fully evaluate the clinical efficacy of granulocytapheresis for BD. https:\/\/pubmed.ncbi.nlm.nih.gov\/16395727\/\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Adacyte\" \/>\n<meta property=\"article:modified_time\" content=\"2021-07-09T11:14:04+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/\",\"url\":\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/\",\"name\":\"Granulocytapheresis in patients with refractory ocular Behcet's disease - Adacyte\",\"isPartOf\":{\"@id\":\"https:\/\/www.adacyte.com\/#website\"},\"datePublished\":\"2006-07-06T09:00:00+00:00\",\"dateModified\":\"2021-07-09T11:14:04+00:00\",\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/\"]}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.adacyte.com\/#website\",\"url\":\"https:\/\/www.adacyte.com\/\",\"name\":\"Adacyte\",\"description\":\"Adacyte Therapeutics\",\"publisher\":{\"@id\":\"https:\/\/www.adacyte.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.adacyte.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.adacyte.com\/#organization\",\"name\":\"Adacyte\",\"url\":\"https:\/\/www.adacyte.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"contentUrl\":\"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg\",\"width\":165,\"height\":46,\"caption\":\"Adacyte\"},\"image\":{\"@id\":\"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Granulocytapheresis in patients with refractory ocular Behcet's disease - Adacyte","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/","og_locale":"es_ES","og_type":"article","og_title":"Granulocytapheresis in patients with refractory ocular Behcet's disease - Adacyte","og_description":"Kenichi Namba&nbsp;1,&nbsp;Koh-Hei Sonoda,&nbsp;Hirokuni Kitamei,&nbsp;Kenji Shiratori,&nbsp;Akiko Ariyama,&nbsp;Kazuya Iwabuchi,&nbsp;Kazunori Ono\u00e9,&nbsp;Abby R Saniabadi,&nbsp;Shoichi Inaba,&nbsp;Tatsuro Ishibashi,&nbsp;Shigeaki Ohno, J Clin Apher. 2006 Jul;21(2):121-8 We conclude that granulocytapheresis might be effective and safe for patients with refractory ocular BD. Further studies are necessary to fully evaluate the clinical efficacy of granulocytapheresis for BD. https:\/\/pubmed.ncbi.nlm.nih.gov\/16395727\/","og_url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/","og_site_name":"Adacyte","article_modified_time":"2021-07-09T11:14:04+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/","url":"https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/","name":"Granulocytapheresis in patients with refractory ocular Behcet's disease - Adacyte","isPartOf":{"@id":"https:\/\/www.adacyte.com\/#website"},"datePublished":"2006-07-06T09:00:00+00:00","dateModified":"2021-07-09T11:14:04+00:00","inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.adacyte.com\/professional\/scientific-corner\/granulocytapheresis-in-patients-with-refractory-ocular-behcets-disease\/"]}]},{"@type":"WebSite","@id":"https:\/\/www.adacyte.com\/#website","url":"https:\/\/www.adacyte.com\/","name":"Adacyte","description":"Adacyte Therapeutics","publisher":{"@id":"https:\/\/www.adacyte.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.adacyte.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.adacyte.com\/#organization","name":"Adacyte","url":"https:\/\/www.adacyte.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","contentUrl":"https:\/\/www.adacyte.com\/wp-content\/uploads\/2021\/01\/logo-adacyte.svg","width":165,"height":46,"caption":"Adacyte"},"image":{"@id":"https:\/\/www.adacyte.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner\/5661","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific-corner"}],"about":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/types\/scientific-corner"}],"wp:attachment":[{"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/media?parent=5661"}],"wp:term":[{"taxonomy":"scientific_tags","embeddable":true,"href":"https:\/\/www.adacyte.com\/es\/wp-json\/wp\/v2\/scientific_tags?post=5661"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}